These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25052254)

  • 61. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery.
    Ceperuelo-Mallafré V; Llauradó G; Keiran N; Benaiges E; Astiarraga B; Martínez L; Pellitero S; González-Clemente JM; Rodríguez A; Fernández-Real JM; Lecube A; Megía A; Vilarrasa N; Vendrell J; Fernández-Veledo S
    Diabetes Care; 2019 Oct; 42(10):1956-1965. PubMed ID: 31375523
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery.
    Souteiro P; Belo S; Neves JS; Magalhães D; Silva RB; Oliveira SC; Costa MM; Saavedra A; Oliveira J; Cunha F; Lau E; Esteves C; Freitas P; Varela A; Queirós J; Carvalho D
    Obes Surg; 2017 Feb; 27(2):288-294. PubMed ID: 27435450
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations.
    Morey-Vargas OL; Aminian A; Steckner K; Zhou K; Kashyap SR; Cetin D; Pantalone KM; Daigle C; Griebeler ML; Butsch WS; Zimmerman R; Kroh M; Saadi HF; Diemer D; Burguera B; Rosenthal RJ; Lansang MC
    Surg Obes Relat Dis; 2022 Aug; 18(8):1087-1101. PubMed ID: 35752593
    [TBL] [Abstract][Full Text] [Related]  

  • 64. EXTERNAL VALIDATION OF THE DIAREM SCORE AS REMISSION PREDICTOR OF DIABETES MELLITUS TYPE 2 IN OBESE PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS.
    Sampaio-Neto J; Nassif LS; Branco-Filho AJ; Bolfarini LA; Loro LS; de Souza MP; Bianco T
    Arq Bras Cir Dig; 2015; 28 Suppl 1(Suppl 1):19-22. PubMed ID: 26537267
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nomogram for Predicting 5-Year Diabetes Remission After Roux-en-Y Gastric Bypass Surgery in Chinese Patients with Obesity.
    Pan Y; Han X; Kam H; Tu Y; Han J; Zhang P; Bao Y; Yu H
    Obes Surg; 2022 May; 32(5):1556-1562. PubMed ID: 35178616
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preoperative Fasting Plasma C-Peptide Levels as Predictors of Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: A Systematic Review and Meta-Analysis.
    Yan W; Bai R; Yan M; Song M
    J Invest Surg; 2017 Dec; 30(6):383-393. PubMed ID: 28045566
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Defining and Using Preoperative Predictors of Diabetic Remission Following Bariatric Surgery.
    Stallard R; Sahai V; Drover JW; Chun S; Keresztes C
    JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):573-580. PubMed ID: 29187047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery.
    Daniele G; Campi B; Saba A; Codini S; Ciccarone A; Giusti L; Del Prato S; Esterline RL; Ferrannini E
    Front Endocrinol (Lausanne); 2020; 11():216. PubMed ID: 32362872
    [No Abstract]   [Full Text] [Related]  

  • 69. Type 2 diabetes remission rates 1-year post-Roux-en-Y gastric bypass and validation of the DiaRem score: the Ontario Bariatric Network experience.
    Honarmand K; Chetty K; Vanniyasingam T; Anvari M; Chetty VT
    Clin Obes; 2017 Jun; 7(3):176-182. PubMed ID: 28349641
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Performance of the DiaRem Score for Predicting Diabetes Remission in Two Health Systems Following Bariatric Surgery Procedures in Hispanic and non-Hispanic White Patients.
    Craig Wood G; Horwitz D; Still CD; Mirshahi T; Benotti P; Parikh M; Hirsch AG
    Obes Surg; 2018 Jan; 28(1):61-68. PubMed ID: 28717860
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study.
    Colosimo S; Martínez-Sánchez MA; Balaguer-Román A; Fernández-Ruiz VE; Núñez-Sánchez MA; Ferrer-Gómez M; Frutos MD; Tomlinson JW; Bertoli S; Marchesini G; Ramos-Molina B
    Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1142-1145. PubMed ID: 38220504
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contribution of glycemic variability to hypoglycemia, and a new marker for diabetes remission after Roux-en-Y gastric bypass surgery.
    Lu J; Pan Y; Tu Y; Zhang P; Zhou J; Yu H
    Surg Obes Relat Dis; 2022 May; 18(5):666-673. PubMed ID: 35190269
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles.
    Cheng V; Kashyap SR; Schauer PR; Kirwan JP; McCrae KR
    Surg Obes Relat Dis; 2013; 9(2):207-12. PubMed ID: 22093380
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Effect of Attrition on Reported Diabetes Remission Rates Following Roux-en-Y Gastric Bypass: a Sensitivity Analysis.
    Isaman DJM; Rothberg AE; Herman WH
    Obes Surg; 2018 May; 28(5):1308-1312. PubMed ID: 29086185
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass.
    Isaman DJ; Rothberg AE; Herman WH
    Diabetes Care; 2016 Dec; 39(12):2247-2253. PubMed ID: 27737910
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reversal of Type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short- and long-duration diabetes.
    Steven S; Carey PE; Small PK; Taylor R
    Diabet Med; 2015 Jan; 32(1):47-53. PubMed ID: 25132043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of the Gut in the Temporal Changes of β-Cell Function After Gastric Bypass in Individuals With and Without Diabetes Remission.
    Prasad M; Mark V; Ligon C; Dutia R; Nair N; Shah A; Laferrère B
    Diabetes Care; 2022 Feb; 45(2):469-476. PubMed ID: 34857533
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of Preoperative Remission Scores and Diabetes Duration Alone as Predictors of Durable Type 2 Diabetes Remission and Risk of Diabetes Complications After Bariatric Surgery: A Post Hoc Analysis of Participants From the Swedish Obese Subjects Study.
    Sjöholm K; Carlsson LMS; Taube M; le Roux CW; Svensson PA; Peltonen M
    Diabetes Care; 2020 Nov; 43(11):2804-2811. PubMed ID: 32873586
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes.
    Dixon JB; Chuang LM; Chong K; Chen SC; Lambert GW; Straznicky NE; Lambert EA; Lee WJ
    Diabetes Care; 2013 Jan; 36(1):20-6. PubMed ID: 23033249
    [TBL] [Abstract][Full Text] [Related]  

  • 80. GLYCEMIC BEHAVIOR IN 48 HOURS POSTOPERATIVE PERIOD OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON DIABETIC SUBMITTED TO BARIATRIC SURGERY.
    de Oliveira LF; Tisott CG; Silvano DM; Campos CM; do Nascimento RR
    Arq Bras Cir Dig; 2015; 28 Suppl 1(Suppl 1):26-30. PubMed ID: 26537269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.